Cargando…

Inhibition of Fatty Acid Oxidation Promotes Macrophage Control of Mycobacterium tuberculosis

Macrophage activation involves metabolic reprogramming to support antimicrobial cellular functions. How these metabolic shifts influence the outcome of infection by intracellular pathogens remains incompletely understood. Mycobacterium tuberculosis (Mtb) modulates host metabolic pathways and utilize...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chandra, Pallavi, He, Li, Zimmerman, Matthew, Yang, Guozhe, Köster, Stefan, Ouimet, Mireille, Wang, Han, Moore, Kathyrn J., Dartois, Véronique, Schilling, Joel D., Philips, Jennifer A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7343992/ https://www.ncbi.nlm.nih.gov/pubmed/32636249 http://dx.doi.org/10.1128/mBio.01139-20

Ejemplares similares

Immune evasion and provocation by Mycobacterium tuberculosis
por: Chandra, Pallavi, et al.
Publicado: (2022)

Macrophage global metabolomics identifies cholestenone as host/pathogen cometabolite present in human Mycobacterium tuberculosis infection
por: Chandra, Pallavi, et al.
Publicado: (2022)

Mycobacterium tuberculosis DprE1 Inhibitor OPC-167832 Is Active against Mycobacterium abscessus In Vitro
por: Sarathy, Jickky Palmae, et al.
Publicado: (2022)

Mycobacterium tuberculosis induces the miR-33 locus to reprogram autophagy and host lipid metabolism
por: Ouimet, Mireille, et al.
Publicado: (2016)

A Mycobacterium tuberculosis NBTI DNA Gyrase Inhibitor Is Active against Mycobacterium abscessus
por: Ganapathy, Uday S., et al.
Publicado: (2021)

Critical discussion on drug efflux in Mycobacterium tuberculosis
por: Remm, Sille, et al.
Publicado: (2021)

The Role of Transport Mechanisms in Mycobacterium Tuberculosis Drug Resistance and Tolerance
por: Sarathy, Jansy Passiflora, et al.
Publicado: (2012)

Gut Microbiota Metabolite Indole Propionic Acid Targets Tryptophan Biosynthesis in Mycobacterium tuberculosis
por: Negatu, Dereje Abate, et al.
Publicado: (2019)

Verapamil Targets Membrane Energetics in Mycobacterium tuberculosis
por: Chen, Chao, et al.
Publicado: (2018)

Strongly Bactericidal All-Oral β-Lactam Combinations for the Treatment of Mycobacterium abscessus Lung Disease
por: Negatu, Dereje A., et al.
Publicado: (2022)

On-Slide Heat Sterilization Enables Mass Spectrometry Imaging of Tissue Infected with High-Threat Pathogens Outside of Biocontainment: A Study Directed at Mycobacterium tuberculosis
por: Wang, Ning, et al.
Publicado: (2021)

The genetic requirements of fatty acid import by Mycobacterium tuberculosis within macrophages
por: Nazarova, Evgeniya V, et al.
Publicado: (2019)

Mycobacterium tuberculosis Inhibits RAB7 Recruitment to Selectively Modulate Autophagy Flux in Macrophages
por: Chandra, Pallavi, et al.
Publicado: (2015)

Extreme Drug Tolerance of Mycobacterium tuberculosis in Caseum
por: Sarathy, Jansy P., et al.
Publicado: (2018)

CinA mediates multidrug tolerance in Mycobacterium tuberculosis
por: Kreutzfeldt, Kaj M., et al.
Publicado: (2022)

Immune activation of the host cell induces drug tolerance in Mycobacterium tuberculosis both in vitro and in vivo
por: Liu, Yancheng, et al.
Publicado: (2016)

Ubiquilin 1 Promotes IFN-γ-Induced Xenophagy of Mycobacterium tuberculosis
por: Sakowski, Erik T., et al.
Publicado: (2015)

Lactate oxidation facilitates growth of Mycobacterium tuberculosis in human macrophages
por: Billig, Sandra, et al.
Publicado: (2017)

Matrix metalloproteinase inhibitors enhance the efficacy of frontline drugs against Mycobacterium tuberculosis
por: Xu, Yitian, et al.
Publicado: (2018)

Potency boost of a Mycobacterium tuberculosis dihydrofolate reductase inhibitor by multienzyme F(420)H(2)-dependent reduction
por: Aragaw, Wassihun Wedajo, et al.
Publicado: (2021)

Single cell preparations of Mycobacterium tuberculosis damage the mycobacterial envelope and disrupt macrophage interactions
por: Mittal, Ekansh, et al.
Publicado: (2023)

Novel Cephalosporins Selectively Active on Nonreplicating Mycobacterium tuberculosis
por: Gold, Ben, et al.
Publicado: (2016)

TBAJ-876, a 3,5-Dialkoxypyridine Analogue of Bedaquiline, Is Active against Mycobacterium abscessus
por: Sarathy, Jickky Palmae, et al.
Publicado: (2020)

Cyclohexyl-griselimycin Is Active against Mycobacterium abscessus in Mice
por: Aragaw, Wassihun Wedajo, et al.
Publicado: (2022)

BCG Induces Protection against Mycobacterium tuberculosis Infection in the Wistar Rat Model
por: Singhal, Amit, et al.
Publicado: (2011)

Plasticity of the Mycobacterium tuberculosis respiratory chain and its impact on tuberculosis drug development
por: Beites, Tiago, et al.
Publicado: (2019)

Blocking Bacterial Naphthohydroquinone Oxidation and ADP-Ribosylation Improves Activity of Rifamycins against Mycobacterium abscessus
por: Ganapathy, Uday S., et al.
Publicado: (2021)

Mycobacterium tuberculosis Type VII Secretion System Effectors Differentially Impact the ESCRT Endomembrane Damage Response
por: Mittal, Ekansh, et al.
Publicado: (2018)

In Vitro Profiling of the Synthetic RNA Polymerase Inhibitor MMV688845 against Mycobacterium abscessus
por: Mann, Lea, et al.
Publicado: (2022)

Author Correction: Lactate oxidation facilitates growth of Mycobacterium tuberculosis in human macrophages
por: Billig, Sandra, et al.
Publicado: (2018)

Mycobacterium tuberculosis Acetyltransferase Suppresses Oxidative Stress by Inducing Peroxisome Formation in Macrophages
por: Behera, Ananyaashree, et al.
Publicado: (2022)

Lung microenvironments harbor Mycobacterium tuberculosis phenotypes with distinct treatment responses
por: Walter, Nicholas D., et al.
Publicado: (2023)

A Ginger Root or Plum Model for the Tuberculosis “Granuloma”?
por: Dartois, Véronique, et al.
Publicado: (2021)

Characterization of In Vitro Resistance to Linezolid in Mycobacterium abscessus
por: Negatu, Dereje A., et al.
Publicado: (2023)

The Dysbiosis Triggered by First-Line Tuberculosis Antibiotics Fails to Reduce Their Bioavailability
por: Namasivayam, Sivaranjani, et al.
Publicado: (2023)

Kasugamycin potentiates rifampicin and limits emergence of resistance in Mycobacterium tuberculosis by specifically decreasing mycobacterial mistranslation
por: Chaudhuri, Swarnava, et al.
Publicado: (2018)

CRISPRi chemical genetics and comparative genomics identify genes mediating drug potency in Mycobacterium tuberculosis
por: Li, Shuqi, et al.
Publicado: (2022)

Incorporation of a Dietary Omega 3 Fatty Acid Impairs Murine Macrophage Responses to Mycobacterium tuberculosis
por: Bonilla, Diana L., et al.
Publicado: (2010)

Insights into battles between Mycobacterium tuberculosis and macrophages
por: Xu, Guanghua, et al.
Publicado: (2014)

Mycobacterium tuberculosis promotes genomic instability in macrophages
por: Castro-Garza, Jorge, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_lf2o4d1e8dlu7nrgbif2f2u94q